New insider activity at Cencora ( (COR) ) has taken place on March 12, 2025.
Lazarus Krikorian, the Senior Vice President and Chief Accounting Officer of Cencora, has recently sold 2,000 shares of the company’s stock. This transaction was valued at $520,120.
Recent Updates on COR stock
Cencora’s stock has seen positive developments recently, with analysts raising price targets due to the company’s strong performance and growth potential. Argus analyst David Toung increased the price target based on Cencora’s robust Q1 results and expected topline growth for the rest of FY25. The company’s strong sales of GLP-1 weight-loss products, along with higher sales of specialty and oncology drugs, are key drivers of its performance. Additionally, Argus has raised its EPS guidance for FY25 and FY26, reflecting confidence in Cencora’s future earnings potential.
More about Cencora
YTD Price Performance: 16.68%
Average Trading Volume: 1,434,043
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $50.72B
Questions or Comments about the article? Write to editor@tipranks.com